Allergan Receives U.S. Subpoena Over Weight Loss Device
This article is for subscribers only.
Allergan Inc., the maker of the wrinkle treatment Botox, received a U.S. government subpoena over its gastric banding device for obesity.
Allergan received the subpoena from the Department of Health and Human Services’s Inspector General this month, the company reported today in a filing. Bonnie Jacobs, a spokeswoman for Irvine, California-based Allergan, acknowledged the subpoena but declined to comment further.